ARTICLE | Clinical News
SciClone regulatory update
September 9, 1996 7:00 AM UTC
China approved Zadaxin thymosin alpha 1 to treat chronic hepatitis B. Zadaxin is a synthetically produced immunomodulator that stimulates the immune system's disease fighting properties. SCLN plans t...